Ovia Health Collaborates With National Birth Equity Collaborative for Black History Month

Siemens Healthineers Launches Enhanced Liver Fibrosis (ELF) Test in the U.S.

February 21, 2022

Labcorp completes acquisition of Personal Genome Diagnostics

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 21, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Personal Genome Diagnostics Inc. ( PGDx ), a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products.
February 9, 2022

Labcorp enters comprehensive, long-term laboratory relationship with Ascension

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 9, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into agreements to create a comprehensive strategic relationship with Ascension, one of the nation’s leading Catholic and non-profit health systems. Through the expansive strategic collaboration, Labcorp will manage Ascension’s hospital-based laboratories in 10 states and purchase select assets of the health system’s outreach laboratory business. This long-term relationship will expand Labcorp’s clinical laboratory services in several states across the country while creating opportunities to enhance care across all clinical areas.